Our mission at Allergenis is transformative: we aim to revolutionize food allergy diagnosis and management, thereby improving the quality of life for over 200 million individuals worldwide. We have already made significant strides. The food allergy epidemic affects 32 million Americans, including one in 13 children, and continues to present potential life-threatening reactions to this entire population. Sadly, it has generated substantial mental, emotional and financial burdens on individuals, parents and caregivers. While tolerance levels and subsequent reactions vary among individuals, existing food allergy testing does not identify these ranges. Current blood-test options in the marketplace produce ambiguous and inaccurate results which lack a full spectrum view of an individual’s allergy. The most commonly administered blood tests have as high as a 60% false-positive rate, while the gold standard tool, an oral food challenge (OFC) is costly, time-consuming, and frequently anxiety-inducing due to the risk of clinical reaction. Allergenis is changing the food allergy diagnostic landscape. Offering patients with more testing options and more clarity on their food allergies.